Literature DB >> 21577203

GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma.

S Kuphal1, G Shaw-Hallgren, M Eberl, S Karrer, F Aberger, A K Bosserhoff, R Massoumi.   

Abstract

CYLD is a deubiquitination enzyme that regulates different cellular processes, such as cell proliferation and cell survival. Mutation and loss of heterozygosity of the CYLD gene causes development of cylindromatosis, a benign tumour originating from the skin. Our study shows that CYLD expression is dramatically downregulated in basal cell carcinoma (BCC), the most common cancer in humans. Reduced CYLD expression in basal cell carcinoma was mediated by GLI1-dependent activation of the transcriptional repressor Snail. Inhibition of GLI1 restored the CYLD expression-mediated Snail signaling pathway, and caused a significant delay in the G1 to S phase transition, as well as proliferation. Our data suggest that GLI1-mediated suppression of CYLD has a significant role in basal cell carcinoma progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21577203     DOI: 10.1038/onc.2011.163

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  CYLD-mediated signaling and diseases.

Authors:  Bryan J Mathis; Yimu Lai; Chen Qu; Joseph S Janicki; Taixing Cui
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium.

Authors:  Jeong Goo Lee; Eric Jung; Martin Heur
Journal:  J Biol Chem       Date:  2018-01-23       Impact factor: 5.157

Review 3.  Regulation of NF-κB by deubiquitinases.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

4.  Whole Scalp Radiation Therapy for Recurrent Benign Cylindromas.

Authors:  Shivam Kaushik; Danielle Siegel; Kenneth Niermann; Neil Newman
Journal:  Case Rep Dermatol       Date:  2022-05-30

5.  Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1.

Authors:  Nitin K Agarwal; Changju Qu; Kranthi Kunkalla; Kranthi Kunkulla; Yadong Liu; Francisco Vega
Journal:  J Biol Chem       Date:  2013-04-10       Impact factor: 5.157

6.  Toll-like receptor-mediated down-regulation of the deubiquitinase cylindromatosis (CYLD) protects macrophages from necroptosis in wild-derived mice.

Authors:  Stephen A Schworer; Irina I Smirnova; Irina Kurbatova; Uliana Bagina; Maria Churova; Trent Fowler; Ananda L Roy; Alexei Degterev; Alexander Poltorak
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

7.  Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.

Authors:  K C Masoumi; Gina Shaw-Hallgren; Ramin Massoumi
Journal:  J Skin Cancer       Date:  2011-12-17

Review 8.  Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential.

Authors:  Jun-Nan Guo; Bai-Rong Xia; Shen-Hui Deng; Chang Yang; Ya-Nan Pi; Bin-Bin Cui; Wei-Lin Jin
Journal:  Front Cell Dev Biol       Date:  2021-06-09

9.  The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.

Authors:  Xin Zheng; Natalia B Rumie Vittar; Xiaohong Gai; Maite G Fernandez-Barrena; Catherine D Moser; Chunling Hu; Luciana L Almada; Angela L McCleary-Wheeler; Sherine F Elsawa; Anne M Vrabel; Abdirashid M Shire; Andrea Comba; Snorri S Thorgeirsson; Youngsoo Kim; Qingguang Liu; Martin E Fernandez-Zapico; Lewis R Roberts
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

10.  The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis.

Authors:  Christophe Chapard; Daniel Hohl; Marcel Huber
Journal:  Oncotarget       Date:  2015-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.